Pay in 4 interest-free payments of $14.50 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
suggesting the involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency
Molecular Weight: 389
Formula: C22H26N4O3
A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury
1186222-89-8
CUDC-907 - PI3K/HDAC dual inhibitor. CAS# 1339928-25-4 size:2mg solid suggesting the involvement of histoneCUDC 907, CAS No. 1339928 25 4, is a potent inhibitor of class I PI3K kinases with an IC50 of 19 nM, 54 nM, 311 nM and 39 nM for PI3K, PI3K, PI3K and PI3K. It also potently inhibits HDAC1, HDAC2, HDAC3, HDAC6, HDAC10 and HDAC11 with IC50 of 1. 7 nM, 5 nM, 1. 8 nM, 27 nM, 2. 8 nM and 5. 4 nM respectively. Through its simultaneous HDAC inhibitory activity, CUDC 907 durably inhibits the PI3K AKT mTOR pathway and compensatory signaling molecules such as